Rastreamento sistemático de condições orofaciais insidiosas em pacientes com câncer de cabeça e pescoço: um estudo de coorte prospectivo
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
CONTEXT: Head and neck cancer (HNC) is the seventh most common type of cancer
worldwide. A systematic approach to HNC patients can aid in diagnosing insidious
orofacial diseases and complications— conditions often overlooked not only by
patients but also by the cancer treatment team. OBJECTIVES: To establish and
implement a protocol for the systematic assessment of HNC patients in order to
monitor the longitudinal progression of oral toxicities during radiotherapy. MATERIALS
AND METHODS: A systematic protocol for the dental assessment of HNC patients
was developed, incorporating validated clinical instruments, structured questionnaires,
and detailed physical examinations. A prospective longitudinal study begun with 42
patients assessed prior to the start of radiotherapy (T0); and 35 of these completed
follow-up through the end of treatment (T2). Clinical assessments were performed at
three time points (T0, T1, and T2), covering oral mucositis, xerostomia, dysphagia,
trismus, orofacial pain, and oral health-related quality of life (OHIP-14). Temporal
progression was analyzed using Cochran's Q and Friedman tests. Generalized
Estimating Equation (GEE) models and Generalized Linear Mixed Models (GLMM)
were employed to identify predictors of outcomes, while Kaplan-Meier analysis
estimated the time to the development of grade ≥2 oral mucositis. RESULTS: A
statistically significant worsening was observed in oral mucositis (40.0% to 77.1%;
p<0.001), trismus (17.1% to 31.4%; p=0.044), dysphagia (68.6% to 88.6%; p=0.050),
and mucositis severity (p<0.001), accompanied by a significant decline in quality of life
(OHIP-14; p=0.025). Xerostomia showed a progressive increase, affecting 88.6% of
patients. Adjusted models demonstrated a strong effect of time on this outcome
(OR=0.098; p<0.001). Orofacial pain maintained a stable prevalence (71.4%); its
intensity was associated with female sex (β=1.758; p=0.033) and mucositis grade
(β=0.572; p=0.005), but not with treatment duration. The absence of mucositis was
strongly associated with a lower occurrence of dysphagia (OR=82.04; p=0.003),
whereas head and neck tumors were associated with greater mucositis severity
(p=0.023). The mean time to develop grade ≥2 mucositis was 32.08 days, with no
difference between sexes (p=0.676). During radiotherapy, only 4 (11.4%) patients
required a nasoenteral tube. CONCLUSIONS: The systematized protocol revealed the
clinical, epidemiological, and dental profile of HNC patients, highlighting a diversity of
lesions and therapeutic complications, as well as the need for specific assessment and
management procedures. In the prospective cohort study, significant progression of
the main orofacial toxicities was observed. Oral mucositis proved to be the primary
clinical determinant of other functional complications, particularly dysphagia and pain
intensity. Orofacial pain showed a high prevalence from the initial assessment
onwards, presenting specific characteristics at each stage but behaving independently
of the treatment's temporal progression. These findings underscore the importance of
longitudinal dental monitoring, early identification of predictive factors, and the
implementation of individualized preventive and therapeutic strategies to reduce oral
morbidity, preserve functionality, and facilitate the continuity of cancer treatment.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

